HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis.

AbstractBACKGROUND:
Multiple studies have evaluated the diagnostic and prognostic performance of conventional troponin (cTn) and high-sensitivity troponin (hs-cTn). We performed a collaborative meta-analysis comparing cTn and hs-cTn for diagnosis of acute myocardial infarction (AMI) and assessment of prognosis in patients with chest pain.
METHODS:
MEDLINE/PubMed, Cochrane CENTRAL, and EMBASE were searched for studies assessing both cTn and hs-cTn in patients with chest pain. Study authors were contacted and many provided previously unpublished data.
RESULTS:
From 17 included studies, there were 8,644 patients. Compared with baseline cTn, baseline hs-cTn had significantly greater sensitivity (0.884 vs 0.749, P < .001) and negative predictive value (NPV; 0.964 vs 0.935, P < .001), whereas specificity (0.816 vs 0.938, P < .001) and positive predictive value (0.558 vs 0.759, P < .001) were significantly reduced. Based on summary receiver operating characteristic curves, test performance for the diagnosis of AMI was not significantly different between baseline cTn and hs-cTn (0.90 [95% CI 0.85-0.95] vs 0.92 [95% CI 0.90-0.94]). In a subanalysis of 6 studies that alternatively defined AMI based on hs-cTn, cTn had lower sensitivity (0.666, P < .001) and NPV (0.906, P < .001). Elevation of baseline hs-cTn, but negative baseline cTn, was associated with increased risk of death or nonfatal myocardial infarction during follow-up (P < .001) compared with both negative.
CONCLUSION:
High-sensitivity troponin has significantly greater early sensitivity and NPV for the diagnosis of AMI at the cost of specificity and positive predictive value, which may enable early rule in/out of AMI in patients with chest pain. Baseline hs-cTn elevation in the setting of negative cTn is also associated with increased nonfatal myocardial infarction or death during follow-up.
AuthorsMichael J Lipinski, Nevin C Baker, Ricardo O Escárcega, Rebecca Torguson, Fang Chen, Sally J Aldous, Michael Christ, Paul O Collinson, Steve W Goodacre, Johannes Mair, Kenji Inoue, Ulrich Lotze, Mustapha Sebbane, Jean-Paul Cristol, Yonathan Freund, Camille Chenevier-Gobeaux, Christophe Meune, Kai M Eggers, Radosław Pracoń, Donald H Schreiber, Alan H B Wu, Jordi Ordoñez-Llanos, Allan S Jaffe, Raphael Twerenbold, Christian Mueller, Ron Waksman
JournalAmerican heart journal (Am Heart J) Vol. 169 Issue 1 Pg. 6-16.e6 (Jan 2015) ISSN: 1097-6744 [Electronic] United States
PMID25497242 (Publication Type: Comparative Study, Journal Article, Meta-Analysis)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Troponin
Topics
  • Chest Pain (blood, etiology)
  • Humans
  • Myocardial Infarction (diagnosis, mortality)
  • Prognosis
  • ROC Curve
  • Sensitivity and Specificity
  • Troponin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: